Edition:
United Kingdom

People: Pfizer Inc (PFE.N)

PFE.N on New York Stock Exchange

42.82USD
9:04pm BST
Change (% chg)

$0.05 (+0.12%)
Prev Close
$42.77
Open
$42.85
Day's High
$43.01
Day's Low
$42.55
Volume
3,251,622
Avg. Vol
6,542,494
52-wk High
$46.46
52-wk Low
$37.14

D'Amelio, Frank 

Mr. Frank A. D'Amelio is the Chief Financial Officer, Executive Vice President - Business Operations of the Company. He was Senior Vice President and Chief Financial Officer from September 2007 until December 2010. Prior to joining Pfizer, he was Senior Executive Vice President of Integration and Chief Administrative Officer of Alcatel-Lucent from November 2006 until August 2007. Prior to the Alcatel-Lucent merger, he was Chief Operating Officer of Lucent and before that Chief Financial Officer of Lucent. Director of Zoetis Inc. and of Humana Inc. and Chair of the Humana Audit Committee. He is a Director of the Independent College Fund of New Jersey.

Basic Compensation

Total Annual Compensation, USD 2,717,920
Restricted Stock Award, USD 2,013,090
Long-Term Incentive Plans, USD --
All Other, USD 2,408,820
Fiscal Year Total, USD 7,139,830

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 292,000 2,777,720.00
Name Fiscal Year Total

Ian Read

19,549,200

Albert Bourla

9,854,560

Frank D'Amelio

7,139,830

Mikael Dolsten

7,070,200

Michael Goettler

--

Angela Hwang

--
As Of  31 Dec 2018